Rheumatology Unit, Department of Internal Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Ann Rheum Dis. 2012 Jan;71(1):67-70. doi: 10.1136/annrheumdis-2011-200022. Epub 2011 Sep 13.
Introduction The early detection of systemic sclerosis (SSc) patients at high risk of developing digital ulcers could allow preventive treatment, with a reduction of morbidity and social costs. In 2009, a quantitative score, the capillaroscopic skin ulcer risk index (CSURI), calculated according to the formula 'D×M/N(2'), was proposed, which was highly predictive of the appearance of scleroderma digital ulcers within 3 months of capillaroscopic evaluation.
This multicentre study aims to validate the predictive value and reproducibility of CSURI in a large population of SSc patients.
CSURI was analysed in 229 unselected SSc patients by nailfold videocapillaroscopy (NVC). All patients were re-evaluated 3 months later with regard to the persistence and/or appearance of new digital ulcers.
57 of 229 patients presented with digital ulcers after 3 months. The receiver operating characteristic curve analysis showed an area under the curve of 0.884 (95% CI 0.835 to 0.922), with specificity and sensitivity of 81.4% (95% CI 74.8 to 86.89) and 92.98% (95% CI 83.0 to 98.0), respectively, at the cut-off value of 2.96. The reproducibility of CSURI was validated on a random sample of 81 patients, with a κ-statistic measure of interrater agreement of 0.8514.
The role of CSURI was confirmed in detecting scleroderma patients with a significantly high risk of developing digital ulcers within the first 3 months from NVC evaluation. CSURI is the only method validated to predict the appearance of digital ulcers and its introduction into routine clinical practice might help optimise the therapeutic strategy of these harmful SSc complications.
本多中心研究旨在验证 CSURI 在大量 SSc 患者中的预测价值和可重复性。
通过甲襞视频显微镜检查(NVC)分析 229 例未经选择的 SSc 患者的 CSURI。所有患者在 3 个月后再次评估是否存在持续性和/或新的手指溃疡。
229 例患者中有 57 例在 3 个月后出现手指溃疡。受试者工作特征曲线分析显示曲线下面积为 0.884(95%CI 0.835 至 0.922),截断值为 2.96 时,特异性和敏感性分别为 81.4%(95%CI 74.8 至 86.89)和 92.98%(95%CI 83.0 至 98.0)。CSURI 的可重复性在 81 例随机患者样本中得到验证,评分者间一致性的κ统计量为 0.8514。
CSURI 在检测 NVC 评估后 3 个月内发生手指溃疡风险显著升高的 SSc 患者方面的作用得到了证实。CSURI 是唯一一种经过验证可预测手指溃疡发生的方法,将其引入常规临床实践可能有助于优化这些有害的 SSc 并发症的治疗策略。